| Literature DB >> 31885925 |
Siriwimon Tantarattanapong1, Lalita Chalongkulasak1.
Abstract
PURPOSE: The objectives of this study were to investigate the predictive factors and develop a clinical prediction score to identify serious intracranial causes in acute nontraumatic headache (NTH).Entities:
Year: 2019 PMID: 31885925 PMCID: PMC6925687 DOI: 10.1155/2019/4267825
Source DB: PubMed Journal: Emerg Med Int ISSN: 2090-2840 Impact factor: 1.112
Figure 1Flow chart of this study.
Baseline characteristics, clinical presentation, and physical examination.
| Characteristic | Nonserious intracranial headache (366 patients) | Serious intracranial headache (88 patients) |
|
|---|---|---|---|
| Age, years, median (IQR) | 54.5 (42, 70) | 51 (40, 64.2) | 0.157 |
| Male | 131 (35.8) | 41 (46.6) | 0.08 |
|
| |||
|
| |||
| Diabetic mellitus | 42 (11.5) | 12 (13.6) | 0.705 |
| Hypertension | 118 (32.2) | 28 (31.8) | 1 |
| Hyperlipidemia | 84 (23) | 18 (20.5) | 0.718 |
| Atrial fibrillation | 12 (3.3) | 1 (1.1) | 0.478 |
| Ischemic heart disease | 17 (4.6) | 3 (3.4) | 0.777 |
| Cerebrovascular disease | 29 (7.9) | 8 (9.1) | 0.887 |
| HIV infection | 5 (1.4) | 7 (8) | 0.003 |
| Malignancy | 21 (5.7) | 14 (15.9) | 0.003 |
|
| |||
|
| |||
| ASA | 46 (12.6) | 7 (8) | 0.305 |
| Clopidogrel | 3 (0.8) | 0 (0) | 1 |
| Anticoagulant | 11 (3) | 4 (4.5) | 0.505 |
| Prednisolone | 0 (0) | 2 (2.3) | 0.037 |
| Hormonal therapy | 1 (0.3) | 3 (3.4) | 0.024 |
|
| |||
|
| |||
| Gradual onset | 308 (84.2) | 55 (62.5) | <0.001 |
| Abrupt onset | 58 (15.8) | 33 (37.5) | <0.001 |
| Duration of headache >1 week | 34 (9.3) | 22 (25) | <0.001 |
| Occipital pain | 60 (16.4) | 21 (23.9) | 0.137 |
| Pain score | 7 (5, 8) | 10 (8, 10) | <0.001 |
| Awakening pain | 41 (11.2) | 42 (47.7) | <0.001 |
| Worst headache ever | 61 (16.7) | 77 (87.5) | <0.001 |
| Neck pain | 61 (16.7) | 29 (33) | <0.001 |
| Nausea/vomiting | 149 (40.7) | 57 (64.8) | <0.001 |
| Fever | 26 (7.1) | 22 (25) | <0.001 |
| Positional provocation | 5 (1.4) | 4 (4.5) | 0.076 |
| Seizure | 5 (1.4) | 7 (8) | 0.003 |
|
| |||
|
| |||
| BT, °C, median (IQR) | 36.6 (36.2, 36.9) | 36.8 (36.2, 37.3) | 0.008 |
| SBP, mmHg, median (IQR) | 144 (128, 161) | 140.5 (127, 162) | 0.621 |
| PR, bpm, median (IQR) | 76 (68, 88) | 77 (67.5, 88.2) | 0.89 |
| RR, breath/min, median (IQR) | 20 (20, 24) | 24 (20, 24) | 0.018 |
| SpO2, %, median (IQR) | 99 (98, 100) | 99 (97, 100) | 0.006 |
| Altered consciousness | 1 (0.3) | 6 (6.8) | <0.001 |
| Localizing neurological deficit | 13 (3.6) | 20 (22.7) | <0.001 |
| Stiffness of neck | 4 (1.1) | 15 (17) | <0.001 |
Data are presented as n (%) unless indicated otherwise. p values <0.05 are statistically significant. IQR = interquartile range; HIV = human immunodeficiency virus; ASA = aspirin; BT = body temperature; SBP = systolic blood pressure; PR = pulse rate; bpm = beats per minute; SpO2 = oxygen saturation.
Comparison of red flag signs and investigations.
| Nonserious intracranial headache (366 patients) | Serious intracranial headache (88 patients) |
| |
|---|---|---|---|
|
| |||
| Age >50 years | 231 (63.1) | 48 (54.5) | 0.174 |
| Abrupt onset | 58 (15.8) | 33 (37.5) | <0.001 |
| Positional provocation | 5 (1.4) | 4 (4.5) | 0.076 |
| Systemic symptoms | 26 (7.1) | 22 (25) | <0.001 |
| Secondary risk factors | 26 (7.1) | 21 (23.9) | <0.001 |
| Neurological deficit | 13 (3.6) | 29 (33) | <0.001 |
|
| |||
|
| |||
| Performed CT brain | 70 (19.1) | 88 (100) | <0.001 |
|
| |||
|
| |||
| Subarachnoid hemorrhage | 0 (0) | 12 (13.6) | <0.001 |
| Intracerebral hemorrhage | 0 (0) | 15 (17.0) | <0.001 |
| Infarction | 0 (0) | 6 (6.8) | <0.001 |
| Tumor with/without complications | 0 (0) | 21 (23.9) | <0.001 |
| Venous sinus thrombosis | 0 (0) | 4 (4.5) | 0.001 |
| Hydrocephalus | 0 (0) | 1 (1.1) | 0.194 |
| Brain abscess | 0 (0) | 1 (1.1) | 0.194 |
| Within normal limits | 70 (19.1) | 28 (31.8) | 0.014 |
| Performed CTA | 0 (0) | 16 (18.2) | <0.001 |
|
| |||
|
| |||
| AVM | 0 (0) | 6 (6.8) | <0.001 |
| Aneurysm | 0 (0) | 7 (8) | <0.001 |
| Within normal limits | 0 (0) | 3 (3.4) | 0.007 |
| Performed MRI | 0 (0) | 23 (26.1) | <0.001 |
|
| |||
|
| |||
| Leptomeningeal enhancement | 0 (0) | 1 (1.1) | 0.194 |
| Focal meningoencephalitis | 0 (0) | 1 (1.1) | 0.194 |
| Brain tumor/metastasis | 0 (0) | 17 (19.3) | <0.001 |
| Cerebral infarction | 0 (0) | 2 (2.3) | 0.037 |
| Venous sinus thrombosis | 0 (0) | 1 (1.1) | 0.194 |
| AVM | 0 (0) | 1 (1.1) | 0.194 |
| Performed lumbar puncture | 5 (1.4) | 26 (29.5) | <0.001 |
|
| |||
|
| |||
| Bacterial meningitis | 0 (0) | 2 (2.3) | 0.037 |
| Viral meningitis | 0 (0) | 12 (13.6) | <0.001 |
| Fungal meningitis | 0 (0) | 6 (6.8) | <0.001 |
| Eosinophilic meningitis | 0 (0) | 1 (1.1) | 0.194 |
| Blood | 0 (0) | 1 (1.1) | 0.194 |
| Normal profile | 5 (1.4) | 4 (4.5) | 0.076 |
|
| |||
|
| |||
| Beta Streptococcus group B | 0 | 1 | |
|
| 0 | 1 | |
|
| 0 | 5 | |
| Human herpes virus | 0 | 2 | |
Data are presented as n (%) unless indicated otherwise. p values <0.05 are statistically significant. CT = computed tomography; CTA = computed tomographic angiography; AVM = arteriovenous malformation; MRI = magnetic resonance imaging.
Final diagnosis of serious intracranial cause of acute nontraumatic headache.
| Final diagnosis | No. of patients (%) |
|---|---|
| Neoplasm | 23 (26.1) |
| Intracranial infection | 22 (25.0) |
| Intracerebral hemorrhage | 15 (17.0) |
| Acute subarachnoid hemorrhage | 13 (14.8) |
| Ischemic stroke | 6 (6.8) |
| Cerebral venous sinus thrombosis | 5 (5.7) |
| Hypertensive encephalopathy | 1 (1.1) |
| Arteriovenous malformation | 1 (1.1) |
| Hydrocephalus | 1 (1.1) |
| Giant cell arteritis | 1 (1.1) |
| Total | 88 (100) |
Multivariable logistic regression model for the predictive factors of serious intracranial cause in acute nontraumatic headache.
| Variables | Crude OR (95% CI) | Adjusted OR (95% CI) |
|
|---|---|---|---|
| Abrupt onset | 3.19 (1.9–5.33) | 7.96 (2.77–22.91) | <0.001 |
| Awakening pain | 7.24 (4.26–12.29) | 3.14 (4.15–6.82) | 0.004 |
| Duration >1 week | 4.06 (2.12–7.78) | 10.59 (2.9–38.7) | <0.001 |
| Fever | 4.36 (2.33–8.15) | 6.01 (2.07–17.46) | <0.001 |
| Worst headache ever | 35 (17.57–69.71) | 12.95 (5.69–29.45) | <0.001 |
| Alteration of consciousness | 40.33 (11.74–138.6) | 13.55 (2.07–88.88) | 0.002 |
| Localizing neurological deficit | 8.36 (3.96–17.63) | 5.28 (1.6–17.46) | 0.019 |
p values <0.05 are statistically significant. OR = odds ratio; CI = confidence interval.
Clinical prediction scores for serious intracranial cause in acute nontraumatic headache.
| Predictive factors | Points |
|---|---|
| Abrupt onset | 1 |
| Awakening pain | 1 |
| Duration >1 week | 1 |
| Fever | 1 |
| Worst headache ever | 2 |
| Alteration of consciousness | 3 |
| Localizing neurological deficit | 1 |
| Total | 10 |
Note: a score of ≥3 points is predictive of serious intracranial cause.
Figure 2Receiver operating characteristic curve derived from the clinical prediction score to diagnose serious intracranial causes in acute nontraumatic headache.